selegiline has been researched along with Depressive Disorder in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (38.71) | 18.7374 |
| 1990's | 18 (29.03) | 18.2507 |
| 2000's | 13 (20.97) | 29.6817 |
| 2010's | 7 (11.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, T; Minami, A; Muraoka, S; Okano, M; Satoyoshi, H; Takahata, K; Tsukamoto, Y; Tsunekawa, H | 1 |
| Goldberg, JF; Thase, ME | 1 |
| Emory, H; Mizrahi, N | 1 |
| Henn, FA; Huston, JP; Petri, D; Schulz, D | 1 |
| Imamura, K; Nagatsu, T; Okayasu, N | 1 |
| Miklya, I | 1 |
| Bodkin, JA; Pae, CU; Patkar, AA; Portland, KB; Thase, ME | 1 |
| Fann, JR | 1 |
| Amsterdam, JD | 1 |
| Bakhle, YS; Youdim, MB | 1 |
| Csoka, AB; Shipko, S | 1 |
| Thase, ME | 1 |
| Preskorn, SH | 1 |
| Goodnick, PJ | 1 |
| Howland, RH | 1 |
| Rapaport, MH; Thase, ME | 1 |
| Lang, AE; Marras, C; McDermott, MP; Naglie, G; Rochon, PA; Tanner, CM | 1 |
| Tobe, EH | 1 |
| Radwan, M; Wijsenbeek, H; Zemishlany, Z | 1 |
| Cohen, RM; Garrick, NA; Karoum, F; Linnoila, M; Murphy, DL; Roy, B; Siever, LJ; Wyatt, RJ | 1 |
| Mendlewicz, J; Youdim, MB | 2 |
| Birkmayer, W; Knoll, J; Linauer, W; Riederer, P | 1 |
| Aarons, SF; Brown, RD; Frances, AJ; Mann, JJ | 1 |
| Davies, SO; Harrison, W; Liebowitz, MR; Markowitz, J; McGrath, PJ; Quitkin, FM; Rabkin, JG; Stewart, JW | 1 |
| Glover, V; Mendis, N; Pare, CM; Sandler, M; Stern, GM | 1 |
| Sandler, M | 1 |
| Frances, A; Gershon, S; Kaplan, RD; Kocsis, J; Mann, JJ; Peselow, ED | 1 |
| Frances, A; Gershon, S; Mann, JJ; Peselow, ED | 1 |
| Asnis, GM; Endicott, J; Halbreich, U; Nathan, RS; Novacenko, H; Ostrow, L; Sachar, EJ | 1 |
| Cohen, RM; Lawlor, BA; Mellow, AM; Molchan, S; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
| Garcia-Monco, JC; Gomez Beldarrain, M; Padierna, A | 1 |
| Youdim, MB | 1 |
| Berry, MD; Juorio, AV; Paterson, IA | 1 |
| Lefebvre, H; Moore, N; Noblet, C; Wolf, LM | 1 |
| Goldstein, B; Schneider, LS; Tariot, PN | 1 |
| Waters, CH | 1 |
| Fahrer, R; Medina, RD; Ortiz Fragola, E; Sabelli, H | 1 |
| Richardson, JS | 1 |
| Bodkin, JA; Cannon, SE; Cohen, BM; Cole, JO; Salomon, MS; Zornberg, GL | 1 |
| Ballering, LA; Steur, EN | 1 |
| Cohen, RM; Karoum, F; Lipper, S; Mellow, AM; Murphy, DL; Pickar, D; Sunderland, T; Tariot, PN | 1 |
| Azzaro, AJ; Gordon, MN; Morgan, DG; Muller, CD; Sherman, KA; Wecker, L | 1 |
| Hillier, CE; Hinds, NP; Wiles, CM | 1 |
| Kuhn, W; Przuntek, H | 1 |
| Agosti, V; Quitkin, FM; Stewart, JW | 1 |
| Lees, AJ | 1 |
| Sabelli, HC | 1 |
| deVries, JD; Suchowersky, O | 1 |
| Aarons, SF; Brown, RP; Frances, AJ; Keilp, JG; Kocsis, JH; Mann, JJ; Pearlstein, T; Sweeney, JA; Wilner, PJ | 1 |
| McGrath, PJ; Quitkin, FM; Stewart, JW | 1 |
| Harrison, W; McGrath, PJ; Nunes, EN; Quitkin, FM; Stewart, JW; Wager, S | 1 |
| Al Mousawi, M; Glover, V; Pare, CM; Sandler, M | 1 |
| Cohen, RM; Garrick, NA; Murphy, DL; Sunderland, T; Tamarkin, L | 1 |
| Birkmayer, W | 1 |
| Knoll, J | 1 |
| Cole, JO | 1 |
| Davies, SO; Karoum, F; Levitt, M; Liebowitz, MR; Linnoila, M; Quitkin, FM; Schwartz, D | 1 |
| Frederickson, E; Palmer, R; Pi, E; Simpson, GM; Sloane, RB; White, K | 1 |
13 review(s) available for selegiline and Depressive Disorder
| Article | Year |
|---|---|
[The feasibility of synthetic enhancer substances for preventive nanotherapy].
Topics: Alzheimer Disease; Animals; Brain Stem; Catecholamines; Depressive Disorder; Feasibility Studies; Humans; Liposomes; Nanomedicine; Neurons; Nootropic Agents; Parkinson Disease; Preventive Medicine; Selegiline; Serotonin; Ubiquitin-Protein Ligases | 2010 |
Neurological effects of psychopharmacological agents.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Bundle-Branch Block; Delirium; Depressive Disorder; Humans; Lithium; Male; Nervous System Diseases; Parkinson Disease; Psychotropic Drugs; Selegiline | 2002 |
Selegiline-transdermal--Somerset: Emsam.
Topics: Administration, Cutaneous; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Depressive Disorder; Drugs, Investigational; Humans; Selegiline | 2003 |
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
Topics: Animals; Cholinesterase Inhibitors; Dementia; Depressive Disorder; History, 20th Century; History, 21st Century; Humans; Indans; Iron; Iron Deficiencies; Isoenzymes; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Selegiline | 2006 |
Seligiline transdermal system in depression.
Topics: Administration, Cutaneous; Depressive Disorder; Drug Delivery Systems; Humans; Psychiatric Status Rating Scales; Selegiline | 2007 |
Transdermal selegiline: a novel MAOI formulation for depression.
Topics: Administration, Cutaneous; Depressive Disorder; Diet; Drug-Related Side Effects and Adverse Reactions; Humans; Monoamine Oxidase Inhibitors; Selegiline | 2006 |
Translating the evidence on atypical depression into clinical practice.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Selegiline | 2007 |
Monoamine oxidase inhibitors--current status.
Topics: Antidepressive Agents, Tricyclic; Brain Chemistry; Catecholamines; Chemical Phenomena; Chemistry; Clorgyline; Depressive Disorder; Drug Interactions; Humans; Hydrazines; Hypertension; Kinetics; Monoamine Oxidase Inhibitors; Phobic Disorders; Receptors, Adrenergic; Receptors, Serotonin; Selegiline; Tyramine | 1983 |
The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
Topics: Benzamides; Cheese; Clorgyline; Depressive Disorder; Humans; Hypertension; Moclobemide; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 1995 |
Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Depressive Disorder; Humans; Longevity; Mental Disorders; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease; Schizophrenia; Selegiline | 1994 |
Therapy with l-deprenyl (selegiline) and relation to abuse liability.
Topics: Alzheimer Disease; Depressive Disorder; Drug Synergism; Humans; Parkinson Disease; Selegiline; Substance-Related Disorders | 1994 |
On the functions of monoamine oxidase, the emotions, and adaptation to stress.
Topics: Adaptation, Psychological; Depressive Disorder; Emotions; Humans; Hypothalamus; Isatin; Limbic System; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Stress Disorders, Post-Traumatic; Stress, Psychological | 1993 |
Selegiline hydrochloride and cognition.
Topics: Aged; Alzheimer Disease; Attention; Dementia; Depressive Disorder; Humans; Mental Recall; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Reaction Time; Selegiline | 1991 |
19 trial(s) available for selegiline and Depressive Disorder
| Article | Year |
|---|---|
The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Blood Circulation Time; Brain; Cerebrovascular Circulation; Depressive Disorder; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Radionuclide Imaging; Selegiline; Treatment Outcome | 2011 |
A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
Topics: Administration, Cutaneous; Adult; Aged; Ambulatory Care; Depressive Disorder; Diet; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Placebos; Psychiatric Status Rating Scales; Selegiline; Treatment Outcome; Tyramine | 2003 |
Clinical efficacy of deprenyl, a specific inhibitor of MAOB.
Topics: Adrenocorticotropic Hormone; Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Mood Disorders; Phenethylamines; Pituitary Gland, Anterior; Receptors, Muscarinic; Selegiline; Tyramine | 1983 |
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.
Topics: Adult; Aged; Bipolar Disorder; Blood Platelets; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Phenethylamines; Selegiline | 1983 |
Studies of selective and reversible monoamine oxidase inhibitors.
Topics: Animals; Benzamides; Blood Platelets; Brain; Clinical Trials as Topic; Depressive Disorder; Dopamine; Double-Blind Method; Drug Interactions; Food; Humans; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Panic; Phenethylamines; Phobic Disorders; Rats; Selegiline; Serotonin; Tyramine | 1984 |
l-Deprenyl in atypical depressives.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emotions; Female; Humans; Male; Phenelzine; Phenethylamines; Placebos; Psychiatric Status Rating Scales; Selegiline | 1984 |
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.
Topics: 5-Hydroxytryptophan; Adult; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenethylamines; Selegiline | 1980 |
Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
Topics: Blood Pressure; Cheese; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Humans; Male; Phenethylamines; Placebos; Selegiline; Tyramine | 1981 |
High-dose selegiline in treatment-resistant older depressive patients.
Topics: Age Factors; Aged; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selegiline; Treatment Outcome | 1994 |
Fluoxetine and selegiline--lack of significant interaction.
Topics: Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Parkinson Disease; Selegiline | 1994 |
Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selegiline; Severity of Illness Index | 1996 |
Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline | 1997 |
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Topics: Biogenic Amines; Chromosome Deletion; Clorgyline; Depressive Disorder; Humans; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Reference Values; Retrospective Studies; Selegiline; Tyramine; X Chromosome | 1998 |
Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants.
Topics: Activities of Daily Living; Adult; Antidepressive Agents; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Male; Personal Satisfaction; Personality Tests; Phenelzine; Selegiline; Single-Blind Method; Social Adjustment | 1991 |
A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Dropouts; Phenethylamines; Placebos; Selegiline | 1989 |
A possible L-deprenyl induced hypertensive reaction.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Hypertension; Male; Phenethylamines; Selegiline | 1989 |
A placebo-controlled trial of L-deprenyl in atypical depression.
Topics: Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Phenethylamines; Placebos; Random Allocation; Selegiline | 1989 |
Where are those new antidepressants we were promised?
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Humans; Legislation, Drug; Mianserin; Nomifensine; Propiophenones; Selegiline; United States; United States Food and Drug Administration | 1988 |
Biochemical effects of L-deprenyl in atypical depressives.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Phenethylamines; Selegiline | 1985 |
30 other study(ies) available for selegiline and Depressive Disorder
| Article | Year |
|---|---|
Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity.
Topics: Animals; Antidepressive Agents; Corticosterone; Depressive Disorder; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Indans; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuronal Plasticity; Prefrontal Cortex; Rats, Wistar; Selegiline; Synaptic Transmission; Time Factors | 2019 |
Monoamine oxidase inhibitors revisited: what you should know.
Topics: Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Humans; Isocarboxazid; Monoamine Oxidase Inhibitors; Phenelzine; Selegiline; Tranylcypromine; Tyramine | 2013 |
Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
Topics: Adult; Depressive Disorder; Diabetes Mellitus, Type 1; Female; Humans; Magnetic Resonance Imaging; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Selegiline; Tranylcypromine | 2016 |
Rats bred for helplessness exhibit positive reinforcement learning deficits which are not alleviated by an antidepressant dose of the MAO-B inhibitor deprenyl.
Topics: Animals; Antidepressive Agents; Appetite; Conditioning, Operant; Depressive Disorder; Disease Models, Animal; Extinction, Psychological; Helplessness, Learned; Learning Disabilities; Male; Monoamine Oxidase Inhibitors; Motivation; Motor Activity; Nootropic Agents; Rats, Sprague-Dawley; Reinforcement, Psychology; Resilience, Psychological; Selegiline; Species Specificity | 2016 |
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.
Topics: Administration, Cutaneous; Adult; Adverse Drug Reaction Reporting Systems; Aged; Depressive Disorder; Drug Eruptions; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Food-Drug Interactions; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self-Injurious Behavior; Tyramine; United States | 2012 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
Topics: Administration, Cutaneous; Chemistry, Pharmaceutical; Depressive Disorder; Drug Approval; Humans; Monoamine Oxidase Inhibitors; Selegiline; United States | 2006 |
Why the transdermal delivery of selegiline (6 mg/24 hr) obviates the need for a dietary restriction on tyramine.
Topics: Administration, Cutaneous; Animals; Depressive Disorder; Diet; Food-Drug Interactions; Guinea Pigs; Humans; Monoamine Oxidase Inhibitors; Selegiline; Tyramine | 2006 |
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.
Topics: Activities of Daily Living; Aged; Canada; Cognition Disorders; Cohort Studies; Depressive Disorder; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Psychological Tests; Quality of Life; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline; Tocopherols; United States | 2008 |
Transdermal selegiline: new opportunity for managing depression.
Topics: Administration, Cutaneous; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Selegiline | 2008 |
Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
Topics: Behavior; Biogenic Amines; Clorgyline; Depressive Disorder; Dopamine; Histamine; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Phenethylamines; Selegiline; Serotonin; Tyramine | 1983 |
Tyramine and depressive illness.
Topics: Animals; Clorgyline; Depressive Disorder; Humans; Phenotype; Rats; Selegiline; Tyramine | 1983 |
L-deprenyl plus L-phenylalanine in the treatment of depression.
Topics: Depressive Disorder; Female; Humans; Male; Phenethylamines; Phenylalanine; Selegiline | 1984 |
Monoamine oxidase inhibitor efficacy in depression and the "cheese effect".
Topics: Animals; Blood Pressure; Cheese; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Selegiline; Tyramine | 1981 |
The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.
Topics: Adult; Blood Platelets; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenethylamines; Selegiline | 1982 |
Differential efficacy of L-deprenyl, a selective MAO type-B inhibitor, in endogenous and nonendogenous depression.
Topics: Depressive Disorder; Humans; Phenethylamines; Selegiline | 1982 |
The dexamethasone suppression test in depressive illness: clinical correlates.
Topics: Depressive Disorder; Desipramine; Dexamethasone; Diagnosis, Differential; Double-Blind Method; Doxepin; Electroconvulsive Therapy; Female; Humans; Hydrocortisone; Imipramine; Male; Mianserin; Middle Aged; Nortriptyline; Phenelzine; Psychiatric Status Rating Scales; Selegiline | 1982 |
Selegiline, fluoxetine, and depression in Parkinson's disease.
Topics: Aged; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Parkinson Disease; Selegiline | 1995 |
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
Topics: Bronchial Spasm; Bronchitis; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Ephedrine; Epinephrine; Humans; Hypertension; Male; Maprotiline; Middle Aged; Norepinephrine; Parkinson Disease; Pheochromocytoma; Selegiline | 1995 |
Phenylethylamine relieves depression after selective MAO-B inhibition.
Topics: Adult; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Phenethylamines; Psychotropic Drugs; Selegiline | 1994 |
Oral versus transdermal selegiline: antidepressant-like activity in rats.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Behavior, Animal; Body Weight; Brain; Depressive Disorder; Dose-Response Relationship, Drug; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Inbred F344; Selegiline; Swimming | 1999 |
Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interactions; Female; Humans; Middle Aged; Nortriptyline; Parkinson Disease; Selegiline; Serotonin Syndrome | 2000 |
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
Topics: Carboxy-Lyases; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline | 1990 |
Rapid treatment of depression with selegiline-phenylalanine combination.
Topics: Adult; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenylalanine; Psychiatric Status Rating Scales; Selegiline | 1991 |
Interaction of fluoxetine and selegiline.
Topics: Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypertension; Middle Aged; Selegiline | 1990 |
Attempts to attenuate the 'cheese effect'. Combined drug therapy in depressive illness.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenethylamines; Selegiline; Tyramine | 1985 |
Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
Topics: Blood Platelets; Clorgyline; Depressive Disorder; Female; Humans; Male; Melatonin; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Receptors, Adrenergic, beta; Selegiline; Tranylcypromine | 1986 |
[Therapeutic strategies and tactics in parkinsonism].
Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders | 1986 |
[Medicamentous strategy for improving the quality of life in the senescence].
Topics: Aged; Catecholamines; Caudate Nucleus; Corpus Striatum; Depressive Disorder; Dopamine; Humans; Monoamine Oxidase; Neural Pathways; Neurons; Parkinson Disease; Phenethylamines; Quality of Life; Receptors, Dopamine; Selegiline; Sexual Behavior; Substantia Nigra | 1986 |
Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
Topics: Blood Platelets; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Monoamine Oxidase; Phenethylamines; Selegiline; Tranylcypromine | 1985 |